Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://karimjfki911758.widblog.com/93758399/retaglutide-a-promising-glp-1-receptor-agonist